Use of biomarkers to diagnose and manage cardiac amyloidosis-Reference-Cited by-同舟云学术

Use of biomarkers to diagnose and manage cardiac amyloidosis

Published:2021-02 Issue:2 Volume:23 Page:217-230
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Castiglione Vincenzo¹,Franzini Maria²,Aimo Alberto¹³,Carecci Alessandro³,Lombardi Carlo Mario⁴,Passino Claudio¹³,Rapezzi Claudio⁵⁶,Emdin Michele¹³,Vergaro Giuseppe¹³

Affiliation:

1. Institute of Life Sciences Scuola Superiore Sant'Anna Pisa Italy

2. Department of Translational Research and of New Surgical and Medical Technologies University of Pisa Pisa Italy

3. Fondazione Toscana Gabriele Monasterio Pisa Italy

4. Department of Medical and Surgical Specialties Radiological Sciences, and Public Health University and Civil Hospital Brescia Italy

5. Centro Cardiologico Universitario di Ferrara University of Ferrara Ferrara Italy

6. Maria Cecilia Hospital GVM Care & Research Cotignola Italy

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.2113

Reference136 articles.

1. Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee

2. Systemic immunoglobulin light chain amyloidosis

3. Relationship between monoclonal gammopathy and cardiac amyloid type

4. Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis

5. Amyloidosis: Insights from Proteomics

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Developments of Hybrid Fluorescence Techniques: Advances inAmyloid Detection Methods;Current Protein & Peptide Science;2024-11

2. Cardiopulmonary exercise testing in transthyretin amyloid cardiomyopathy patients: a long-term follow-up study;Journal of Cardiovascular Medicine;2024-07-15

3. Pathophysiology of Cardiac Amyloidosis;Heart Failure Clinics;2024-07

4. Clinical Use of Biomarkers in Cardiac Amyloidosis;Heart Failure Clinics;2024-07

5. Tafamidis in the Treatment of ATTR-related Cardiomyopathy;Heart Failure Clinics;2024-07